Research and Markets: Pharmaceutical Production in Germany Accounts for Around 10% of World Pharmaceutical Output and is Second Largest Pharmaceutical Exporter Behind USA
Research and Markets (http://www. researchandmarkets. com/reports/c17377) has announced the addition of Germany Pharmaceutical Market Intelligence Report to their offering.
Dublin (PRWEB) May 16, 2005
Research and Markets (http://www. researchandmarkets. com/reports/c17377 (http://www. researchandmarkets. com/reports/c17377)) has announced the addition of Germany Pharmaceutical Market Intelligence Report to their offering.
Germany is the third largest pharmaceutical market in the world and the largest in Europe. Although the domestic consumption of pharmaceuticals is being constrained by government policy, the export market continues to expand. Germany also has the largest generics market in Europe.
Recent IMF data suggests that German economic growth is minimal, which is also slowing growth in other European countries. By virtue of the size of the German economy, it would appear that instead of the German economy stimulating other European economies, it is having the opposite effect.
Major healthcare reforms were introduced in January 2004. One of the aims was to reduce the average contribution rate to health insurance companies. Another was to reduce overall pharmaceutical expenditure, especially by the statutory health insurance (GKV). In both of these aims, the government can claim some success.
The German pharmaceutical industry is under severe price constraints and methods imposed by the government limit pharmaceutical expenditure. Coupled with increasing compulsory manufacturer discounts, the pharmaceutical market is unlikely to expand in the coming year.
Pharmaceutical production in Germany accounts for around 10% of the world pharmaceutical output and is the second largest pharmaceutical exporter behind the USA. Germany remains a strong base for R&D activities, with 16.2% of sales being reinvested into R&D.
This report is ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. The report opens with an outlook section that provides analysis of the market and, importantly, provides 5-year market forecasts, national data projections, outlook and key developments such as regulation, pricing/reimbursement, health facilities and government policy.
The report also provides background information, population trends, health status, health expenditure, organisation & administration, medical services and personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts.
For more information visit http://www. researchandmarkets. com/reports/c17377 (http://www. researchandmarkets. com/reports/c17377)
Laura Wood
Senior Manager
Research and Markets
Press@researchandmarkets. com
Fax: +353 1 4100 980
###
